Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-09-16 Sale |
2021-09-17 7:58 pm |
EXELIXIS INC. | EXEL | Haley Patrick J. EVP, Commercial |
25,000 | $20.36 | $509,000 | 315,181 (Indirect Direct) |
View |
2021-09-15 Sale |
2021-09-17 7:56 pm |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
47,500 | $20.46 | $971,850 | 549,072 (Indirect Direct) |
View |
2021-08-16 Sale |
2021-08-18 7:56 pm |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
55,000 | $18.44 | $1,014,200 | 406,572 (Indirect Direct) |
View |
2021-07-15 Sale |
2021-07-16 7:58 pm |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
60,000 | $17.47 | $1,048,200 | 461,572 (Indirect Direct) |
View |
2021-06-17 Sale |
2021-06-22 8:03 pm |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
60,000 | $22.18 | $1,330,800 | 521,572 (Indirect Direct) |
View |
2021-05-18 Sale |
2021-05-18 8:13 pm |
EXELIXIS INC. | EXEL | Haley Patrick J. EVP, Commercial |
14,593 | $24.73 | $360,885 | 315,181 (Indirect Direct) |
View |
2021-05-11 Sale |
2021-05-17 8:15 pm |
EXELIXIS INC. | EXEL | Freire Maria C Director |
8,275 | $25.01 | $206,958 | 31,827 (Direct) |
View |
2021-05-14 Sale |
2021-05-17 8:13 pm |
EXELIXIS INC. | EXEL | MARCHESI VINCENT T Director |
40,000 | $25.04 | $1,001,600 | 66,115 (Direct) |
View |
2021-05-14 Sale |
2021-05-17 8:11 pm |
EXELIXIS INC. | EXEL | POSTE GEORGE Director |
40,802 | $24.97 | $1,018,826 | 157,190 (Direct) |
View |
2021-05-13 Sale |
2021-05-14 8:35 pm |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
100,000 | $25.38 | $2,538,000 | 778,958 (Indirect Direct) |
View |
2021-05-11 Sale |
2021-05-13 8:32 pm |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
20,770 | $24.98 | $518,794 | 1,288,127 (Direct) |
View |
2021-04-26 Sale |
2021-04-28 8:10 pm |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
50,000 | $25 | $1,250,000 | 628,362 (Indirect Direct) |
View |
2021-04-26 Sale |
2021-04-28 8:08 pm |
EXELIXIS INC. | EXEL | Haley Patrick J. EVP, Commercial |
7,665 | $25.03 | $191,855 | 331,579 (Indirect Direct) |
View |
2021-04-26 Sale |
2021-04-28 8:06 pm |
EXELIXIS INC. | EXEL | Hessekiel Jeffrey EVP and General Counsel |
18,000 | $25.03 | $450,540 | 629,247 (Indirect Direct) |
View |
2021-04-01 Sale |
2021-04-02 7:51 pm |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
60,000 | $22.96 | $1,377,600 | 406,572 (Indirect Direct) |
View |
2021-04-01 Sale |
2021-04-02 7:41 pm |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
50,000 | $23 | $1,150,000 | 678,362 (Indirect Direct) |
View |
2021-03-29 Sale |
2021-03-31 9:02 pm |
EXELIXIS INC. | EXEL | WYSZOMIERSKI JACK L Director |
6,220 | $22.64 | $140,821 | 231,589 (Direct) |
View |
2021-03-15 Sale |
2021-03-17 8:11 pm |
EXELIXIS INC. | EXEL | Garber Alan M Director |
40,000 | $23.6 | $944,000 | 12,718 (Direct) |
View |
2021-03-01 Sale |
2021-03-03 7:49 pm |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
65,000 | $22.11 | $1,437,150 | 417,177 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-09-21 Exercise |
2021-09-23 8:16 pm |
2016-07-15 2022-07-14 |
EXELIXIS INC. | EXEL | Senner Christopher J. EVP and CFO |
90,000 | $0 | 394,257 (Direct) |
View |
2021-09-21 Exercise |
2021-09-23 8:16 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Senner Christopher J. EVP and CFO |
90,000 | $3.66 | 394,257 (Direct) |
View |
2021-09-21 Tax Withholding |
2021-09-23 8:16 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Senner Christopher J. EVP and CFO |
55,057 | $20.33 | 394,257 (Direct) |
View |
2021-09-16 Exercise |
2021-09-17 7:58 pm |
2015-07-20 2021-09-18 |
EXELIXIS INC. | EXEL | Haley Patrick J. EVP, Commercial |
25,000 | $0 | 315,181 (Direct) |
View |
2021-09-16 Exercise |
2021-09-17 7:58 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Haley Patrick J. EVP, Commercial |
25,000 | $1.7 | 315,181 (Direct) |
View |
2021-09-15 Exercise |
2021-09-17 7:56 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
47,500 | $6.21 | 549,072 (Direct) |
View |
2021-09-15 Exercise |
2021-09-17 7:56 pm |
2016-09-16 2022-09-15 |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
47,500 | $0 | 549,072 (Direct) |
View |
2021-08-16 Exercise |
2021-08-18 7:56 pm |
2015-07-20 2022-02-04 |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
55,000 | $0 | 406,572 (Direct) |
View |
2021-08-16 Exercise |
2021-08-18 7:56 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
55,000 | $1.9 | 406,572 (Direct) |
View |
2021-07-26 Exercise |
2021-07-28 8:06 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
40,000 | $4.2 | 703,958 (Direct) |
View |
2021-07-26 Exercise |
2021-07-28 8:06 pm |
2017-02-11 2023-02-10 |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
40,000 | $0 | 703,958 (Direct) |
View |
2021-07-21 Exercise |
2021-07-23 7:47 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
35,000 | $4.2 | 703,958 (Direct) |
View |
2021-07-21 Exercise |
2021-07-23 7:47 pm |
2017-02-11 2023-02-10 |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
35,000 | $0 | 703,958 (Direct) |
View |
2021-07-15 Exercise |
2021-07-16 7:58 pm |
2015-07-20 2022-02-04 |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
60,000 | $0 | 461,572 (Direct) |
View |
2021-07-15 Exercise |
2021-07-16 7:58 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
60,000 | $1.9 | 461,572 (Direct) |
View |
2021-07-06 Exercise |
2021-07-08 7:45 pm |
N/A N/A |
EXELIXIS INC. | EXEL | COHEN CHARLES Director |
40,000 | $6.3 | 261,375 (Direct) |
View |
2021-07-06 Exercise |
2021-07-08 7:45 pm |
2015-05-28 2022-05-27 |
EXELIXIS INC. | EXEL | COHEN CHARLES Director |
80,000 | $0 | 261,375 (Direct) |
View |
2021-07-06 Exercise |
2021-07-08 7:45 pm |
N/A N/A |
EXELIXIS INC. | EXEL | COHEN CHARLES Director |
40,000 | $3.13 | 261,375 (Direct) |
View |
2021-06-17 Exercise |
2021-06-22 8:03 pm |
2015-07-20 2022-02-04 |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
60,000 | $0 | 521,572 (Direct) |
View |
2021-06-17 Exercise |
2021-06-22 8:03 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
60,000 | $1.9 | 521,572 (Direct) |
View |
2021-05-27 Option Award |
2021-05-28 8:38 pm |
2021-05-27 2028-05-26 |
EXELIXIS INC. | EXEL | WYSZOMIERSKI JACK L Director |
24,897 | $0 | 256,486 (Direct) |
View |
2021-05-27 Option Award |
2021-05-28 8:35 pm |
2021-05-27 2028-05-26 |
EXELIXIS INC. | EXEL | FELDBAUM CARL B Director |
33,549 | $0 | 33,549 (Direct) |
View |
2021-05-27 Option Award |
2021-05-28 8:32 pm |
2021-05-27 2028-05-26 |
EXELIXIS INC. | EXEL | WILLSEY LANCE Director |
33,549 | $0 | 33,549 (Direct) |
View |
2021-05-27 Option Award |
2021-05-28 8:28 pm |
2021-05-27 2028-05-26 |
EXELIXIS INC. | EXEL | MARCHESI VINCENT T Director |
24,897 | $0 | 91,012 (Direct) |
View |
2021-05-27 Option Award |
2021-05-28 8:26 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
16,424 | $0 | 1,304,551 (Direct) |
View |
2021-05-27 Option Award |
2021-05-28 8:21 pm |
2021-05-27 2028-05-26 |
EXELIXIS INC. | EXEL | Freire Maria C Director |
24,897 | $0 | 56,724 (Direct) |
View |
2021-05-27 Option Award |
2021-05-28 8:19 pm |
2021-05-27 2028-05-26 |
EXELIXIS INC. | EXEL | COHEN CHARLES Director |
33,549 | $0 | 33,549 (Direct) |
View |
2021-05-27 Option Award |
2021-05-28 8:17 pm |
2021-05-27 2028-05-26 |
EXELIXIS INC. | EXEL | Garber Alan M Director |
33,549 | $0 | 33,549 (Direct) |
View |
2021-05-27 Option Award |
2021-05-28 8:13 pm |
N/A N/A |
EXELIXIS INC. | EXEL | POSTE GEORGE Director |
16,424 | $0 | 173,614 (Direct) |
View |
2021-05-27 Option Award |
2021-05-28 8:08 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Smith Julie Director |
16,424 | $0 | 32,725 (Direct) |
View |
2021-05-15 Tax Withholding |
2021-05-18 8:13 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Haley Patrick J. EVP, Commercial |
3,026 | $25.56 | 315,181 (Direct) |
View |
2021-05-14 Exercise |
2021-05-17 8:13 pm |
N/A N/A |
EXELIXIS INC. | EXEL | MARCHESI VINCENT T Director |
40,000 | $6.3 | 66,115 (Direct) |
View |
2021-05-14 Exercise |
2021-05-17 8:13 pm |
2016-05-26 2023-05-25 |
EXELIXIS INC. | EXEL | MARCHESI VINCENT T Director |
40,000 | $0 | 66,115 (Direct) |
View |
2021-05-12 Exercise |
2021-05-14 8:51 pm |
N/A N/A |
EXELIXIS INC. | EXEL | MORRISSEY MICHAEL President and CEO |
50,000 | $4.2 | 1,648,330 (Direct) |
View |
2021-05-12 Tax Withholding |
2021-05-14 8:51 pm |
N/A N/A |
EXELIXIS INC. | EXEL | MORRISSEY MICHAEL President and CEO |
30,278 | $25.16 | 1,648,330 (Direct) |
View |
2021-05-12 Exercise |
2021-05-14 8:51 pm |
2017-02-11 2023-02-10 |
EXELIXIS INC. | EXEL | MORRISSEY MICHAEL President and CEO |
50,000 | $0 | 1,648,330 (Direct) |
View |
2021-05-10 Gift |
2021-05-14 8:51 pm |
N/A N/A |
EXELIXIS INC. | EXEL | MORRISSEY MICHAEL President and CEO |
60,338 | $0 | 1,648,330 (Indirect) |
View |
2021-05-13 Exercise |
2021-05-14 8:35 pm |
2015-07-20 2022-02-04 |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
100,000 | $0 | 778,958 (Direct) |
View |
2021-05-13 Exercise |
2021-05-14 8:35 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
100,000 | $1.9 | 778,958 (Direct) |
View |
2021-05-11 Exercise |
2021-05-13 8:32 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
40,000 | $3.38 | 1,288,127 (Direct) |
View |
2021-05-11 Exercise |
2021-05-13 8:32 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
40,000 | $6.3 | 1,288,127 (Direct) |
View |
2021-05-11 Exercise |
2021-05-13 8:32 pm |
2016-05-26 2023-05-25 |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
120,000 | $0 | 1,288,127 (Direct) |
View |
2021-05-11 Exercise |
2021-05-13 8:32 pm |
N/A N/A |
EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director |
40,000 | $3.13 | 1,288,127 (Direct) |
View |
2021-04-26 Exercise |
2021-04-28 8:10 pm |
2015-07-20 2021-09-18 |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
50,000 | $0 | 628,362 (Direct) |
View |
2021-04-26 Exercise |
2021-04-28 8:10 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
50,000 | $1.7 | 628,362 (Direct) |
View |
2021-04-01 Exercise |
2021-04-02 7:51 pm |
2015-07-20 2021-09-18 |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
60,000 | $0 | 406,572 (Direct) |
View |
2021-04-01 Exercise |
2021-04-02 7:51 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
60,000 | $1.7 | 406,572 (Direct) |
View |
2021-04-01 Exercise |
2021-04-02 7:41 pm |
2015-07-20 2021-09-18 |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
50,000 | $0 | 678,362 (Direct) |
View |
2021-04-01 Exercise |
2021-04-02 7:41 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
50,000 | $1.7 | 678,362 (Direct) |
View |
2021-03-29 Exercise |
2021-03-31 9:02 pm |
N/A N/A |
EXELIXIS INC. | EXEL | WYSZOMIERSKI JACK L Director |
40,000 | $3.38 | 231,589 (Direct) |
View |
2021-03-29 Exercise |
2021-03-31 9:02 pm |
2014-05-29 2021-05-28 |
EXELIXIS INC. | EXEL | WYSZOMIERSKI JACK L Director |
40,000 | $0 | 231,589 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 8:11 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Garber Alan M Director |
40,000 | $3.38 | 12,718 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 8:11 pm |
2014-05-29 2021-05-28 |
EXELIXIS INC. | EXEL | Garber Alan M Director |
40,000 | $0 | 12,718 (Direct) |
View |
2021-03-04 Option Award |
2021-03-05 8:04 pm |
2022-03-04 2028-03-03 |
EXELIXIS INC. | EXEL | MORRISSEY MICHAEL President and CEO |
494,700 | $0 | 2,063,924 (Direct) |
View |
2021-02-24 Gift |
2021-03-05 8:04 pm |
N/A N/A |
EXELIXIS INC. | EXEL | MORRISSEY MICHAEL President and CEO |
67,374 | $0 | 2,063,924 (Direct) |
View |
2021-03-04 Option Award |
2021-03-05 8:03 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Schwab Gisela Pres, Prod Dev & Med Aff & CMO |
72,885 | $0 | 628,362 (Direct) |
View |
2021-03-04 Option Award |
2021-03-05 8:01 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Hessekiel Jeffrey EVP and General Counsel |
57,135 | $0 | 647,247 (Direct) |
View |
2021-03-04 Option Award |
2021-03-05 8:00 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Senner Christopher J. EVP and CFO |
64,150 | $0 | 359,314 (Direct) |
View |
2021-03-04 Option Award |
2021-03-05 7:58 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Haley Patrick J. EVP, Commercial |
59,570 | $0 | 339,244 (Direct) |
View |
2021-03-04 Option Award |
2021-03-05 7:56 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
49,395 | $0 | 406,572 (Direct) |
View |
2021-03-01 Exercise |
2021-03-03 7:49 pm |
2015-07-20 2021-09-18 |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
65,000 | $0 | 417,177 (Direct) |
View |
2021-03-01 Exercise |
2021-03-03 7:49 pm |
N/A N/A |
EXELIXIS INC. | EXEL | Lamb Peter EVP, Scientific Strategy & CSO |
65,000 | $1.7 | 417,177 (Direct) |
View |